These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9462172)

  • 21. Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications.
    Aho K; Palusuo T; Kurki P
    Semin Arthritis Rheum; 1994 Jun; 23(6):379-87. PubMed ID: 7524151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis.
    Burgos PI; Causey ZL; Tamhane A; Kelley JM; Brown EE; Hughes LB; Danila MI; van Everdingen A; Conn DL; Jonas BL; Callahan LF; Smith EA; Brasington RD; Moreland LW; van der Heijde DM; Alarcón GS; Bridges SL
    Arthritis Res Ther; 2010; 12(3):R75. PubMed ID: 20444266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
    Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
    Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression.
    Forslind K; Vincent C; Serre G; Svensson B
    Scand J Rheumatol; 2001; 30(4):221-4. PubMed ID: 11578017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.
    Hayem G; Chazerain P; Combe B; Elias A; Haim T; Nicaise P; Benali K; Eliaou JF; Kahn MF; Sany J; Meyer O
    J Rheumatol; 1999 Jan; 26(1):7-13. PubMed ID: 9918234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic markers of radiographic progression in early rheumatoid arthritis.
    Goronzy JJ; Matteson EL; Fulbright JW; Warrington KJ; Chang-Miller A; Hunder GG; Mason TG; Nelson AM; Valente RM; Crowson CS; Erlich HA; Reynolds RL; Swee RG; O'Fallon WM; Weyand CM
    Arthritis Rheum; 2004 Jan; 50(1):43-54. PubMed ID: 14730598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
    Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
    J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies.
    Meyer O; Tauxe F; Fabregas D; Gabay C; Goycochea M; Haim T; Elias A; Kahn MF
    Clin Exp Rheumatol; 1993; 11(5):473-8. PubMed ID: 7506130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.
    Vasiliauskiene L; Wiik A; Høier-Madsen M
    Ann Rheum Dis; 2001 May; 60(5):459-66. PubMed ID: 11302867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.
    Vincent C; de Keyser F; Masson-Bessière C; Sebbag M; Veys EM; Serre G
    Ann Rheum Dis; 1999 Jan; 58(1):42-8. PubMed ID: 10343539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospect for an additional laboratory criterion for rheumatoid arthritis.
    von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K
    Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis.
    van Jaarsveld CH; ter Borg EJ; Jacobs JW; Schellekens GA; Gmelig-Meyling FH; van Booma-Frankfort C; de Jong BA; van Venrooij WJ; Bijlsma JW
    Clin Exp Rheumatol; 1999; 17(6):689-97. PubMed ID: 10609067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.
    Vittecoq O; Pouplin S; Krzanowska K; Jouen-Beades F; Menard JF; Gayet A; Daragon A; Tron F; Le Loet X
    Rheumatology (Oxford); 2003 Aug; 42(8):939-46. PubMed ID: 12730503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis.
    Morel J; Roch-Bras F; Molinari N; Sany J; Eliaou JF; Combe B
    Ann Rheum Dis; 2004 Dec; 63(12):1581-6. PubMed ID: 15547082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease.
    Mustila A; Paimela L; Leirisalo-Repo M; Huhtala H; Miettinen A
    Arthritis Rheum; 2000 Jun; 43(6):1371-7. PubMed ID: 10857797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
    Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
    Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
    Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P
    J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
    Berglin E; Padyukov L; Sundin U; Hallmans G; Stenlund H; Van Venrooij WJ; Klareskog L; Dahlqvist SR
    Arthritis Res Ther; 2004; 6(4):R303-8. PubMed ID: 15225365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
    Quinn MA; Gough AK; Green MJ; Devlin J; Hensor EM; Greenstein A; Fraser A; Emery P
    Rheumatology (Oxford); 2006 Apr; 45(4):478-80. PubMed ID: 16287917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.
    Meyer O; Nicaise-Roland P; Santos MD; Labarre C; Dougados M; Goupille P; Cantagrel A; Sibilia J; Combe B
    Arthritis Res Ther; 2006; 8(2):R40. PubMed ID: 16469118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.